Researchers have found that patients who waited longer to begin chemotherapy after surgery may be at a 55 per cent higher ...

Gastroenterologists reveal the number-one sign of colon cancer. Plus, other symptoms to watch for and why the illness can be ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A three-year exercise program improved ...

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality compared with those not taking the drugs. The mortality benefit was statistically ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and Mounjaro) had substantially lower five-year death rates than those not using ...

In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took GLP-1 ...